Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4673950014 | Bambuterol and montelukast only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4673951013 | Product containing only bambuterol and montelukast in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bambuterol and montelukast only product in oral dose form | Is a | Bambuterol and montelukast only product | true | Inferred relationship | Some | ||
Bambuterol and montelukast only product in oral dose form | Is a | Bambuterol- and montelukast-containing product in oral dose form | true | Inferred relationship | Some | ||
Bambuterol and montelukast only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Bambuterol and montelukast only product in oral dose form | Has active ingredient | Montelukast (substance) | true | Inferred relationship | Some | 1 | |
Bambuterol and montelukast only product in oral dose form | Has active ingredient | Bambuterol (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Bambuterol and montelukast only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets